Schedule 13G ownership disclosure

Intec Pharma Ltd.

Security class unavailable · CUSIP: M53644106

Event date: 2020-02-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,117,195
Percent of class
Unavailable

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-024500
Form type
SC 13G/A
Filer
Dexcel Pharma Technologies Ltd.
CIK
CIK 1720007
Filed
Feb 25, 2020
Reporting period
Feb 21, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub